On (b)(6) 2022 a representative of johnson and johnson vision care received notification from an eye care professional (ecp) in the united kingdom that a patient (pt) required hospital treatment for severe neovascularization while wearing acuvue oasys® 1-day contact lenses with hydraluxe¿ technology contact lenses (cls).
On (b)(6) 2022, the johnson and johnson representative advised that the ecp refused to provide any additional information regarding the pt¿s event.
The ecp also refused to provide the pt¿s contact information as the pt didn¿t want to be contacted.
The ecp reported ¿the incident is not necessarily due to the cls themselves.
No additional medical information was provided.
The date of the event is unknown, therefore the received date of the complaint ((b)(6) 2022) will be used as the date of event.
It is unknown which eye(s) was affected.
The suspect lot number was not provided.
No additional investigation can be conducted.
This event will be submitted as a worst-case event as we were unable to verify the pt¿s diagnosis and treatment.
It is unknown if the suspect contact lens(es) are available for return for evaluation.
If any further relevant information is received, a supplemental report will be filed.
|